Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Colorcon
McKesson
AstraZeneca
Johnson and Johnson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Hikma Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and eighty-one approved drugs.

There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.

Drugs and US Patents for Hikma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 040337-002 Feb 16, 2000 DISCN No No   Start Trial   Start Trial
Hikma Farmaceutica MILRINONE LACTATE IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 090038-001 Jan 21, 2010 AP RX No No   Start Trial   Start Trial
Hikma TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075498-004 Apr 12, 2001 AB RX No No   Start Trial   Start Trial
Hikma Farmaceutica FLUCONAZOLE IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 076736-001 Aug 23, 2005 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HIKMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
Express Scripts
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.